Tamir Meiri

Techsomed Medical Technologies Ltd. develops and manufactures ultrasound based real-time monitoring systems for thermal ablation procedures. It offers monitoring and prediction of the progression of tissue destruction during an ablation procedure. The company was founded by Yossi Abu and Eyal Melamed in 2012 and is headquartered in Rehovot, Israel.

Techsomed Medical Technologies Ltd. develops and manufactures ultrasound based real-time monitoring systems for thermal ablation procedures. It offers monitoring and prediction of the progression of tissue destruction during an ablation procedure. The company was founded by Yossi Abu and Eyal Melamed in 2012 and is headquartered in Rehovot, Israel.

Solenic Medical, Inc. operates as a medical device company. It develops and commercializes a method for preventing prosthetic joint infection (PJI) based on technology. The firm?s technology offers an apparatus for the eradication of biofilm from metallic implants. The company was founded by David Greenberg and Rajiv Chopra in 2019 and is headquartered in College Station, TX.

Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Ovuline, Inc. designs and develops applications for women?s health. It designed two applications, Ovia Fertility and Ovia Pregnancy, to track women?s fertility and pregnancy and also provide users with a feedback loop for their symptoms. The company was founded by Alex Baron and Paris Wallace in June, 2012 and is headquartered in Boston, MA.

Ovuline, Inc. designs and develops applications for women?s health. It designed two applications, Ovia Fertility and Ovia Pregnancy, to track women?s fertility and pregnancy and also provide users with a feedback loop for their symptoms. The company was founded by Alex Baron and Paris Wallace in June, 2012 and is headquartered in Boston, MA.

Ovuline, Inc. designs and develops applications for women?s health. It designed two applications, Ovia Fertility and Ovia Pregnancy, to track women?s fertility and pregnancy and also provide users with a feedback loop for their symptoms. The company was founded by Alex Baron and Paris Wallace in June, 2012 and is headquartered in Boston, MA.

Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation.

Solenic Medical, Inc. operates as a medical device company. It develops and commercializes a method for preventing prosthetic joint infection (PJI) based on technology. The firm?s technology offers an apparatus for the eradication of biofilm from metallic implants. The company was founded by David Greenberg and Rajiv Chopra in 2019 and is headquartered in College Station, TX.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Ovuline, Inc. designs and develops applications for women?s health. It designed two applications, Ovia Fertility and Ovia Pregnancy, to track women?s fertility and pregnancy and also provide users with a feedback loop for their symptoms. The company was founded by Alex Baron and Paris Wallace in June, 2012 and is headquartered in Boston, MA.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation.

Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation.

Rythm SAS develops a device which helps to monitor and analyze the sleep. Its product, Dreem, is a sleep solution that monitors, analyzes, and acts on brain to enhance sleep. The company was founded by Hugo Mercier and Quentin Soulet de Brugière in 2014 and is headquartered in Paris, France.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Solenic Medical, Inc. operates as a medical device company. It develops and commercializes a method for preventing prosthetic joint infection (PJI) based on technology. The firm?s technology offers an apparatus for the eradication of biofilm from metallic implants. The company was founded by David Greenberg and Rajiv Chopra in 2019 and is headquartered in College Station, TX.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

HiDoc Technologies GmbH develops a platform which enables patients to take control of their digestive health through smart mobile applications. The company was founded by Andre Sommer, Dankrad Feist, Jesaja Brinkmann and Orest Tarasiuk in 2016 and is headquartered in Berlin, Germany.

Ovuline, Inc. designs and develops applications for women?s health. It designed two applications, Ovia Fertility and Ovia Pregnancy, to track women?s fertility and pregnancy and also provide users with a feedback loop for their symptoms. The company was founded by Alex Baron and Paris Wallace in June, 2012 and is headquartered in Boston, MA.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation.

Techsomed Medical Technologies Ltd. develops and manufactures ultrasound based real-time monitoring systems for thermal ablation procedures. It offers monitoring and prediction of the progression of tissue destruction during an ablation procedure. The company was founded by Yossi Abu and Eyal Melamed in 2012 and is headquartered in Rehovot, Israel.

Ovuline, Inc. designs and develops applications for women?s health. It designed two applications, Ovia Fertility and Ovia Pregnancy, to track women?s fertility and pregnancy and also provide users with a feedback loop for their symptoms. The company was founded by Alex Baron and Paris Wallace in June, 2012 and is headquartered in Boston, MA.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Ovuline, Inc. designs and develops applications for women?s health. It designed two applications, Ovia Fertility and Ovia Pregnancy, to track women?s fertility and pregnancy and also provide users with a feedback loop for their symptoms. The company was founded by Alex Baron and Paris Wallace in June, 2012 and is headquartered in Boston, MA.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

HiDoc Technologies GmbH develops a platform which enables patients to take control of their digestive health through smart mobile applications. The company was founded by Andre Sommer, Dankrad Feist, Jesaja Brinkmann and Orest Tarasiuk in 2016 and is headquartered in Berlin, Germany.

Rythm SAS develops a device which helps to monitor and analyze the sleep. Its product, Dreem, is a sleep solution that monitors, analyzes, and acts on brain to enhance sleep. The company was founded by Hugo Mercier and Quentin Soulet de Brugière in 2014 and is headquartered in Paris, France.

Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation.

Ovuline, Inc. designs and develops applications for women?s health. It designed two applications, Ovia Fertility and Ovia Pregnancy, to track women?s fertility and pregnancy and also provide users with a feedback loop for their symptoms. The company was founded by Alex Baron and Paris Wallace in June, 2012 and is headquartered in Boston, MA.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Ovuline, Inc. designs and develops applications for women?s health. It designed two applications, Ovia Fertility and Ovia Pregnancy, to track women?s fertility and pregnancy and also provide users with a feedback loop for their symptoms. The company was founded by Alex Baron and Paris Wallace in June, 2012 and is headquartered in Boston, MA.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Rythm SAS develops a device which helps to monitor and analyze the sleep. Its product, Dreem, is a sleep solution that monitors, analyzes, and acts on brain to enhance sleep. The company was founded by Hugo Mercier and Quentin Soulet de Brugière in 2014 and is headquartered in Paris, France.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Techsomed Medical Technologies Ltd. develops and manufactures ultrasound based real-time monitoring systems for thermal ablation procedures. It offers monitoring and prediction of the progression of tissue destruction during an ablation procedure. The company was founded by Yossi Abu and Eyal Melamed in 2012 and is headquartered in Rehovot, Israel.

Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation.

Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation.

Solenic Medical, Inc. operates as a medical device company. It develops and commercializes a method for preventing prosthetic joint infection (PJI) based on technology. The firm?s technology offers an apparatus for the eradication of biofilm from metallic implants. The company was founded by David Greenberg and Rajiv Chopra in 2019 and is headquartered in College Station, TX.

Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation.

Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation.

Solenic Medical, Inc. operates as a medical device company. It develops and commercializes a method for preventing prosthetic joint infection (PJI) based on technology. The firm?s technology offers an apparatus for the eradication of biofilm from metallic implants. The company was founded by David Greenberg and Rajiv Chopra in 2019 and is headquartered in College Station, TX.

HiDoc Technologies GmbH develops a platform which enables patients to take control of their digestive health through smart mobile applications. The company was founded by Andre Sommer, Dankrad Feist, Jesaja Brinkmann and Orest Tarasiuk in 2016 and is headquartered in Berlin, Germany.

HiDoc Technologies GmbH develops a platform which enables patients to take control of their digestive health through smart mobile applications. The company was founded by Andre Sommer, Dankrad Feist, Jesaja Brinkmann and Orest Tarasiuk in 2016 and is headquartered in Berlin, Germany.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.